Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03312270 · ClinicalTrials.gov registry record · NA
Strategies to Accommodate Reading (STAR)
A NA study, sponsored by Miami University.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT03312270 is a NA study that has completed, run by Miami University. The registered enrollment target is 152 participants.
The verdict
NCT03312270, a NA study, has completed, sponsored by Miami University.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
People with aphasia often understand spoken utterances better than written sentences. They also benefit from having content appear in multiple rather than single modalities. Because text-to-speech (TTS) systems accommodate both of these functions, it provides an ideal basis for a reading intervention. TTS systems convert written text to provide both text and auditory information. Research about using TTS supports with people with aphasia has not extended beyond basic case studies and our studies of sentence level comprehension. Hence, no evidence exists about varying TTS features-such as speech output, speech rate, and text highlighting-known to benefit others with reading problems. Also, social acceptance of TTS is not well understood, even though it is critical to adoption and long-term use of the technology. The purpose of this study is to evaluate various aspects of multimodality presentation of material through TTS systems used by people with aphasia. The immediate outcome of the proposed research will be evidence-based recommendations for selecting and adjusting TTS systems and features. This work will enable clinicians to maximize benefits for adults with varying aphasia profiles. We also will obtain initial evidence about the social validity and perceived value of TTS system use for this population.
Interventions
- BEHAVIORAL Multimodality information comprehension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03312270
The ClinicalTrials.gov registry entry for NCT03312270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Miami University, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multimodality information comprehension is the first listed.
NCT03312270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03312270 about?
NCT03312270 is a clinical study titled "Strategies to Accommodate Reading (STAR)". People with aphasia often understand spoken utterances better than written sentences. They also benefit from having content appear in multiple rather than single modalities. Because text-to-speech (TTS) systems accommodate both of these functions, it provides an ideal basis for a reading interventio...
What is the current status of trial NCT03312270?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2018-05-01. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT03312270?
The interventions under investigation include: Multimodality information comprehension (BEHAVIORAL).
Who is sponsoring clinical trial NCT03312270?
This trial is sponsored by Miami University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.